September 17, 2021
SNMMI’s 10th Annual Patient Education Day drew more than 220 patients, caregivers, and advocates, providing insights into the role of nuclear medicine and molecular imaging in disease diagnosis, staging, and treatment.
Each year the Society’s Outreach Domain works with the SNMMI Patient Advocacy Advisory Board to hold a Patient Education Day in conjunction with the Annual Meeting. This year’s event was the second to be held virtually; it took place over three Saturdays in August. Nuclear medicine physicians, radiologists, technologists, oncologists, and patients from throughout the United States and the world presented sessions on nuclear medicine and radiation safety as well as disease-specific information regarding neuroendocrine tumors, prostate cancer, and breast cancer.
Engagement during the live sessions was high, with more than 50 questions asked on the virtual platform, and the post-event evaluations were extremely positive, with attendees rating the Overall Program a 9.58 out of 10.
Among the attendee comments:
Each year on the Patient Education Day evaluation form, SNMMI asks patients, “How safe do you believe nuclear medicine procedures are?” The response from this year’s attendees was 4.58/5, (with 5 being “very safe”). This compares with a score of 3.34/5 among the general population according to a 2017 SNMMI survey of more than 600 patients who had received a nuclear medicine scan or treatment.
For more information on Patient Education Day and to watch the recordings of this year’s sessions, visit www.snmmi.org/ped.